EchoIQ Limited (ECHOiQ) is an Australia-based health and medical technology company. The Company is engaged in the product development, marketing and commercialization of software products and services. It provides cardiac diagnostics technology. The Company has developed cloud-based decision-support software, EchoSolv, powered by artificial intelligence (AI) and machine learning, which aims to provide physicians with a reliable tool to identify patients at-risk of structural heart disease. ECHOiQ’s technology uses AI assisted diagnostics to deliver real-world health solutions. Its screening program uses an AI backed system and access to cardiac big data that identifies patients at risk from aortic stenosis and other forms of structural heart disease. The Company’s technology addresses aortic stenosis, heart failure, and mitral and tricuspid regurgitation.